Tokyo Tape
Sign in
← Takara Holdings

Half-year report · Q2

2531.TEDINET S100UNIS
Period2024-04-01 → 2024-09-30
Filed2024-11-11
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥176.5bn2024-04-01 → 2024-09-30Cons.Net sales
Revenue¥339.4bn2023-04-01 → 2024-03-31Cons.Net sales (5-year summary)
Revenue¥163.2bn2023-04-01 → 2023-09-30Cons.Net sales
Operating income¥10.5bn2024-04-01 → 2024-09-30Cons.Operating income
Operating income¥12.5bn2023-04-01 → 2023-09-30Cons.Operating income
Ordinary income¥11.2bn2024-04-01 → 2024-09-30Cons.Ordinary income
Ordinary income¥23.3bn2023-04-01 → 2024-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥13.0bn2023-04-01 → 2023-09-30Cons.Ordinary income
Profit before tax¥13.7bn2024-04-01 → 2024-09-30Cons.Income before income taxes
Profit before tax¥13.0bn2023-04-01 → 2023-09-30Cons.Income before income taxes
Net income (owners)¥9.1bn2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥16.2bn2023-04-01 → 2024-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥8.0bn2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income¥9.7bn2024-04-01 → 2024-09-30Cons.Profit loss
Net income¥9.0bn2023-04-01 → 2023-09-30Cons.Profit loss
Total assets¥447.8bnat 2024-09-30Cons.Assets
Total assets¥437.5bnat 2024-03-31Cons.Assets
Total assets¥420.9bnat 2023-09-30Cons.Total assets (5-year summary)
Total liabilities¥151.4bnat 2024-09-30Cons.Liabilities
Total liabilities¥157.0bnat 2024-03-31Cons.Liabilities
Net assets / equity¥296.5bnat 2024-09-30Cons.Net assets
Net assets / equity¥280.5bnat 2024-03-31Cons.Net assets
Net assets / equity¥272.1bnat 2023-09-30Cons.Net assets (5-year summary)
Cash and deposits¥95.1bnat 2024-09-30Cons.Cash and deposits
Cash and deposits¥95.1bnat 2024-03-31Cons.Cash and deposits
Cash & equivalents¥89.9bnat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥90.2bnat 2024-03-31Cons.Cash and cash equivalents
Cash & equivalents¥84.4bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥91.8bnat 2023-03-31dCons.Cash and cash equivalents
Operating cash flow¥6.2bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥29.2bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥14.9bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥2.3bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥20.0bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥15.8bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥9.1bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥13.4bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥9.7bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥46.552024-04-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥82.092023-04-01 → 2024-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥40.692023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio54.0%at 2024-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio52.3%at 2024-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio52.2%at 2023-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 54
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2024-04-01 → 2024-09-30¥15.4bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2024-04-01 → 2024-09-30¥6.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2024-04-01 → 2024-09-30¥8.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2024-04-01 → 2024-09-30¥1.4bn
Reconciling Itemsreconcilingrevenue2024-04-01 → 2024-09-30−¥9.6bn
Reconciling Itemsreconcilingrevenue intersegment2024-04-01 → 2024-09-30−¥9.6bn
Reconciling Itemsreconcilingsegment profit2024-04-01 → 2024-09-30−¥395m
jpcrp040300-q2r_E00396-000Takara Bio Groupreportable segmentrevenue2024-04-01 → 2024-09-30¥89.0bn
jpcrp040300-q2r_E00396-000Takara Bio Groupreportable segmentrevenue external2024-04-01 → 2024-09-30¥88.8bn
jpcrp040300-q2r_E00396-000Takara Bio Groupreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥227m
jpcrp040300-q2r_E00396-000Takara Bio Groupreportable segmentsegment profit2024-04-01 → 2024-09-30¥6.5bn
jpcrp040300-q2r_E00396-000Takara Healthcarereportable segmentrevenue2024-04-01 → 2024-09-30¥19.8bn
jpcrp040300-q2r_E00396-000Takara Healthcarereportable segmentrevenue external2024-04-01 → 2024-09-30¥19.8bn
jpcrp040300-q2r_E00396-000Takara Healthcarereportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥0
jpcrp040300-q2r_E00396-000Takara Healthcarereportable segmentsegment profit2024-04-01 → 2024-09-30¥417m
jpcrp040300-q2r_E00396-000Takara Shuzo Groupreportable segmentrevenue2024-04-01 → 2024-09-30¥62.0bn
jpcrp040300-q2r_E00396-000Takara Shuzo Groupreportable segmentrevenue external2024-04-01 → 2024-09-30¥61.5bn
jpcrp040300-q2r_E00396-000Takara Shuzo Groupreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥504m
jpcrp040300-q2r_E00396-000Takara Shuzo Groupreportable segmentsegment profit2024-04-01 → 2024-09-30¥2.6bn
—segment totalrevenue2024-04-01 → 2024-09-30¥170.7bn
—segment totalrevenue external2024-04-01 → 2024-09-30¥170.0bn
—segment totalrevenue intersegment2024-04-01 → 2024-09-30¥732m
—segment totalsegment profit2024-04-01 → 2024-09-30¥9.5bn
Total Of Reportable Segments And Otherssegment totalrevenue2024-04-01 → 2024-09-30¥186.1bn
Total Of Reportable Segments And Otherssegment totalrevenue external2024-04-01 → 2024-09-30¥176.5bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2024-04-01 → 2024-09-30¥9.6bn
Total Of Reportable Segments And Otherssegment totalsegment profit2024-04-01 → 2024-09-30¥10.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-04-01 → 2023-09-30¥14.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-04-01 → 2023-09-30¥6.5bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2023-04-01 → 2023-09-30¥8.4bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-04-01 → 2023-09-30¥1.2bn
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-09-30−¥9.2bn
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-09-30−¥9.2bn
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-09-30−¥348m
jpcrp040300-q2r_E00396-000Takara Bio Groupreportable segmentrevenue2023-04-01 → 2023-09-30¥77.2bn
jpcrp040300-q2r_E00396-000Takara Bio Groupreportable segmentrevenue external2023-04-01 → 2023-09-30¥76.9bn
jpcrp040300-q2r_E00396-000Takara Bio Groupreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥282m
jpcrp040300-q2r_E00396-000Takara Bio Groupreportable segmentsegment profit2023-04-01 → 2023-09-30¥6.3bn
jpcrp040300-q2r_E00396-000Takara Healthcarereportable segmentrevenue2023-04-01 → 2023-09-30¥19.1bn
jpcrp040300-q2r_E00396-000Takara Healthcarereportable segmentrevenue external2023-04-01 → 2023-09-30¥19.1bn
jpcrp040300-q2r_E00396-000Takara Healthcarereportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥0
jpcrp040300-q2r_E00396-000Takara Healthcarereportable segmentsegment profit2023-04-01 → 2023-09-30¥1.4bn
jpcrp040300-q2r_E00396-000Takara Shuzo Groupreportable segmentrevenue2023-04-01 → 2023-09-30¥61.2bn
jpcrp040300-q2r_E00396-000Takara Shuzo Groupreportable segmentrevenue external2023-04-01 → 2023-09-30¥60.7bn
jpcrp040300-q2r_E00396-000Takara Shuzo Groupreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥486m
jpcrp040300-q2r_E00396-000Takara Shuzo Groupreportable segmentsegment profit2023-04-01 → 2023-09-30¥4.0bn
—segment totalrevenue2023-04-01 → 2023-09-30¥157.5bn
—segment totalrevenue external2023-04-01 → 2023-09-30¥156.7bn
—segment totalrevenue intersegment2023-04-01 → 2023-09-30¥768m
—segment totalsegment profit2023-04-01 → 2023-09-30¥11.6bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-09-30¥172.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-09-30¥163.2bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-09-30¥9.2bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-09-30¥12.8bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 520
ItemContextValueUnit
Other nclPrior1YearInstant42187000000JPY
Other nclCurrentQuarterInstant44085000000JPY
Noncurrent liabilitiesPrior1YearInstant76345000000JPY
Noncurrent liabilitiesCurrentQuarterInstant73278000000JPY
LiabilitiesPrior1YearInstant157003000000JPY
LiabilitiesCurrentQuarterInstant151359000000JPY
Capital stockPrior1YearInstant13226000000JPY
Capital stockCurrentQuarterInstant13226000000JPY
Capital surplusPrior1YearInstant2716000000JPY
Capital surplusCurrentQuarterInstant2804000000JPY
Retained earningsPrior1YearInstant169909000000JPY
Retained earningsCurrentQuarterInstant173335000000JPY
Treasury stockPrior1YearInstant-2103000000JPY
Treasury stockCurrentQuarterInstant-2103000000JPY
Shareholders equityPrior1YearInstant183749000000JPY
Shareholders equityCurrentQuarterInstant187262000000JPY
Valuation difference on available for sale securitiesPrior1YearInstant22511000000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant17024000000JPY
Deferred gains or losses on hedgesPrior1YearInstant3000000JPY
Deferred gains or losses on hedgesCurrentQuarterInstant-3000000JPY
Foreign currency translation adjustmentPrior1YearInstant22389000000JPY
Foreign currency translation adjustmentCurrentQuarterInstant37374000000JPY
Remeasurements of defined benefit plansPrior1YearInstant12000000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant89000000JPY
Valuation and translation adjustmentsPrior1YearInstant44915000000JPY
Valuation and translation adjustmentsCurrentQuarterInstant54485000000JPY
Non controlling interestsPrior1YearInstant51799000000JPY
Non controlling interestsCurrentQuarterInstant54702000000JPY
Net assetsPrior1YearInstant280465000000JPY
Net assetsCurrentQuarterInstant296451000000JPY
Liabilities and net assetsPrior1YearInstant437468000000JPY
Liabilities and net assetsCurrentQuarterInstant447811000000JPY
Net salesPrior1YTDDuration163172000000JPY
Net salesCurrentYTDDuration176539000000JPY
Cost of salesPrior1YTDDuration107713000000JPY
Cost of salesCurrentYTDDuration117794000000JPY
Gross profitPrior1YTDDuration55459000000JPY
Gross profitCurrentYTDDuration58745000000JPY
Selling general and administrative expensesPrior1YTDDuration42995000000JPY
Selling general and administrative expensesCurrentYTDDuration48212000000JPY
Operating incomePrior1YTDDuration12464000000JPY
Operating incomeCurrentYTDDuration10532000000JPY
Interest income noiPrior1YTDDuration153000000JPY
Interest income noiCurrentYTDDuration408000000JPY
Dividends income noiPrior1YTDDuration496000000JPY
Dividends income noiCurrentYTDDuration492000000JPY
Other noiPrior1YTDDuration397000000JPY
Other noiCurrentYTDDuration406000000JPY
Non operating incomePrior1YTDDuration1048000000JPY
Non operating incomeCurrentYTDDuration1306000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2024-03-31pass
balance sheet identityconsolidated 2024-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-03-31pass
statement vs summary · net assetsconsolidated 2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · total assetsconsolidated 2024-03-31pass
statement vs summary · total assetsconsolidated 2024-09-30pass